Bovine Respiratory Disease Treatment Market – Increase in bovine production due to increasing demand from manufacturers is expected to drive market growth
Bovine respiratory disease is the most common disease in cattle, affecting the lower respiratory system and producing bronchopneumonia which can lead to death. It is a multifactorial syndrome triggered by the association of a viral infection and a bacterial agent, amplified by stress. Mannheimia hemolytica, Pasteurella multocida and Hemophilus somnus are among the bacteria responsible for bovine respiratory disease, as are viral agents such as bovine viral diarrhea (BVD), infectious bovine rhinotracheitis (IBR), parainfluenza virus type 3 ( PI-3), and bovine respiratory syncytial virus (BRSV).
The global bovine respiratory disease treatment market is expected to grow as beef production increases in response to increasing demand for animal meat.
Get Sample Copy of 2021 Market Report @
According to a 2016 study published in the Turkish Journal of Veterinary and Animal Sciences, bovine respiratory disease (BRD) is the most common disease in cattle, contributing around 75% of morbidity and more than 50% of deaths from cows. In the near future, the increasing prevalence of BRD in cattle is expected to propel the growth of the global bovine respiratory disease treatment market.
Beef production is one of the most important industries in the United States, according to a study released by the United States Department of Agriculture (USDA) in 2016. It was valued at US $ 78.2 billion in 2015. As the population increases, the need for cow meat and dairy products, which accelerates the pace of cattle farming. Inadvertently, increased cow husbandry increases the prevalence of BRD in cattle. In the near future, this is expected to create a favorable atmosphere for the growth of the global bovine respiratory disease treatment market.
The global bovine respiratory disease treatment market is divided into three categories: disease, treatment type, and distribution channel.
Due to the increasing prevalence of bovine respiratory disease, North America is expected to account for the largest share of the global bovine respiratory disease treatment market.
Due to the increasing prevalence of bovine respiratory disease in the region, North America is expected to dominate the bovine respiratory disease treatment market. Bovine respiratory disease (BRD) is a global health problem that is most common in cattle in North America, according to the 2014 Symposium on Bovine Respiratory Diseases.
In the United States, BRD is responsible for 70-80% of all feedlot morbidity and 40-50% of all deaths. Due to the increase in cattle breeding in China, the Bovine Respiratory Disease market in Asia-Pacific is expected to experience substantial growth. According to a report released in 2017 by the US Department of Agriculture, China is the world’s second-largest exporter of beef.
Request a sample PDF copy of the report @
The increasing development of innovative treatment methods for bovine respiratory diseases is expected to drive the growth of the global bovine respiratory disease treatment market during the forecast period
The major players operating in the global bovine respiratory disease treatment market are Bimeda Animal Health, Elanco, Virbac Group, Bayer AG, Zoetis Inc., Merck & Co. Inc., Boehringer Ingelheim GmbH and Vetoquinol.
Bayer launched in 2015, the immunostimulant Zelnate, a treatment for bovine respiratory disease (BRD) that successfully reduces BRD-related death and lung injury in cattle. The US Department of Agriculture has approved Zelnate, the first immunostimulant based on the cytosine-phosphate-guanine (CpG) motif.
Reasons to buy this report
• Gain an in-depth understanding of the global bovine respiratory disease treatment market
• Identify current trends and expected growth over the next nine years
• To assist industry consultants, the Bovine Respiratory Disease Treatment market, other stakeholders are aligning their market-centric strategies
• To drive research-based business decisions and add weight to presentations and marketing strategies
• Acquire competitive knowledge of the main market players
Buy this full activity report at a discount of US $ 2000 @
Global Bovine Respiratory Disease Treatment Market Research Report
Section 1: Global Bovine Respiratory Disease Treatment Industry Overview
Section 2: Global economic impact on the bovine respiratory disease treatment industry
Section 3: Competition in the world market by industry producers
Section 4: World productions, income (value), by region
Article 5: Global supply (production), consumption, export, import, geographically
Article 6: World productions, income (value), price trend, product type
Article 7: Global market analysis, based on the application
Article 8: Bovine Respiratory Disease Treatment Market Price Analysis
Article 9: Market chain, sourcing strategy and downstream buyers
Article 10: Key strategies and policies of distributors / suppliers / traders
Article 11: Analysis of the key marketing strategy, by market suppliers
Article 12: Analysis of market effect factors
Article 13: Global Bovine Respiratory Disease Treatment Market Forecast
Coherent Market Insights is a global market intelligence and consulting organization focused on helping our plethora of clients achieve transformational growth by helping them make critical business decisions. We have our head office in India, an office at Global Financial Capital in the United States, and business consultants in the United Kingdom and Japan. Our clientele includes players from various industries in more than 150 countries around the world. We pride ourselves on serving clients from all walks of life, from Fortune 500 companies to nonprofits and startups looking to gain a foothold in the market. We excel in providing unmatched actionable market insights across various industry verticals including chemicals & materials, healthcare, food & beverage, consumer goods, packaging, semiconductors, software and services, telecommunications and automotive. We offer syndicated market intelligence reports, customized research solutions and advisory services.
Consistent market information
1001 4th Ave, # 3200 Seattle, WA 98154, USA
Email: [email protected]
United States of America: + 1-206-701-6702
United Kingdom: + 44-020-8133-4027
Japan: + 050-5539-1737
India: + 91-848-285-0837